Roche Reports Strong Sales Growth and Optimistic Outlook for 2026
Roche continues to show strong momentum in the first half of 2026, achieving a sales growth of +6% at constant exchange rates, despite a decline of -2% when measured in Swiss francs due to currency fluctuations. The company forecasts a mid single digit increase in Group sales and a high single digit growth in core earnings per share for 2026, alongside an expected increase in dividends.
Outlook for 2026
Roche (SIX: RO, ROP; OTCQX: RHHBY) expects an increase in Group sales in the mid single digit range (CER) for 2026. Core earnings per share are targeted to develop in the high single digit range (CER). Roche expects to further increase its dividend in Swiss francs.